UBAP2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.997000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.253200E-01
Normal-vs-Stage2
5.363000E-01
Normal-vs-Stage3
1.827570E-01
Normal-vs-Stage4
2.680200E-01
Stage1-vs-Stage2
1.174760E-01
Stage1-vs-Stage3
9.675800E-02
Stage1-vs-Stage4
7.353800E-01
Stage2-vs-Stage3
6.404300E-02
Stage2-vs-Stage4
4.822400E-01
Stage3-vs-Stage4
5.568400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.132000E-01
Normal-vs-AfricanAmerican
8.804200E-01
Normal-vs-Asian
3.925000E-01
Caucasian-vs-AfricanAmerican
4.535400E-01
Caucasian-vs-Asian
6.584800E-01
AfricanAmerican-vs-Asian
3.395200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.946200E-01
Normal-vs-Female
5.243400E-01
Male-vs-Female
9.598200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.336000E-01
Normal-vs-Age(41-60Yrs)
3.643200E-01
Normal-vs-Age(61-80Yrs)
5.712000E-01
Normal-vs-Age(81-100Yrs)
5.743800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.007200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.572400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.595600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.126400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.852400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.844800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.058200E-01
Normal-vs-Daily Drinker
7.158200E-01
Normal-vs-Weekly Drinker
4.034800E-01
Normal-vs-Occasional Drinker
3.578000E-01
Normal-vs-Social Drinker
1.570770E-01
Non Drinker-vs-Daily Drinker
7.169800E-01
Non Drinker-vs-Weekly Drinker
1.798590E-01
Non Drinker-vs-Occasional Drinker
2.198800E-01
Non Drinker-vs-Social Drinker
1.096820E-01
Daily Drinker-vs-Weekly Drinker
3.783600E-01
Daily Drinker-vs-Occasional Drinker
4.682200E-01
Daily Drinker-vs-Social Drinker
2.513400E-01
Weekly Drinker-vs-Occasional Drinker
7.579600E-01
Weekly Drinker-vs-Social Drinker
9.918200E-01
Occasional Drinker-vs-Social Drinker
6.957200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.484800E-01
Normal-vs-Grade 2
1.294410E-01
Normal-vs-Grade 3
1.564030E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.029000E-01
Grade 1-vs-Grade 3
7.973400E-01
Grade 1-vs-Grade 4
2.484800E-01
Grade 2-vs-Grade 3
8.232800E-01
Grade 2-vs-Grade 4
1.294410E-01
Grade 3-vs-Grade 4
1.564030E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.922600E-01
Normal-vs-NonDiabetic
4.622800E-01
Diabetic-vs-NonDiabetic
2.672400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.840800E-01
Normal-vs-NoPancreatitis
5.285000E-01
Pancreatitis-vs-NoPancreatitis
9.269400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.388600E-01
Normal-vs-N1
5.246000E-01
N0-vs-N1
8.678600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.814600E-01
Normal-vs-TP53-NonMutant
3.847800E-01
TP53-Mutant-vs-TP53-NonMutant
9.568000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
